Molina Healthcare (NYSE:MOH) Price Target Cut to $331.00 by Analysts at Robert W. Baird

Molina Healthcare (NYSE:MOH) had its target price decreased by analysts at Robert W. Baird from $405.00 to $331.00 in a research note issued on Thursday, Benzinga reports. The firm currently has an “outperform” rating on the stock. Robert W. Baird’s price objective suggests a potential upside of 1.67% from the stock’s previous close.

A number of other research firms also recently commented on MOH. Stephens reaffirmed an “equal weight” rating and issued a $320.00 target price on shares of Molina Healthcare in a research report on Thursday, July 25th. StockNews.com raised Molina Healthcare from a “hold” rating to a “buy” rating in a report on Friday, October 18th. Deutsche Bank Aktiengesellschaft reduced their target price on Molina Healthcare from $354.00 to $353.00 and set a “hold” rating for the company in a report on Monday, July 29th. Jefferies Financial Group dropped their price target on Molina Healthcare from $354.00 to $297.00 and set a “hold” rating on the stock in a research note on Wednesday, July 24th. Finally, Truist Financial reduced their price objective on Molina Healthcare from $440.00 to $400.00 and set a “buy” rating for the company in a research note on Monday, July 15th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating, six have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Molina Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $367.00.

Molina Healthcare Stock Up 0.6 %

Shares of NYSE MOH opened at $325.56 on Thursday. The business has a 50-day moving average of $335.23 and a two-hundred day moving average of $330.07. The company has a market capitalization of $19.08 billion, a price-to-earnings ratio of 17.84, a price-to-earnings-growth ratio of 0.99 and a beta of 0.58. Molina Healthcare has a 1 year low of $272.69 and a 1 year high of $423.92. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.57 and a quick ratio of 1.57.

Molina Healthcare (NYSE:MOH) last posted its earnings results on Wednesday, October 23rd. The company reported $6.01 earnings per share for the quarter, topping the consensus estimate of $5.96 by $0.05. The firm had revenue of $10.34 billion during the quarter, compared to analysts’ expectations of $9.92 billion. Molina Healthcare had a return on equity of 28.09% and a net margin of 2.84%. The firm’s revenue was up 21.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $5.05 earnings per share. On average, analysts forecast that Molina Healthcare will post 23.5 earnings per share for the current fiscal year.

Insider Buying and Selling at Molina Healthcare

In other news, CAO Maurice Hebert sold 393 shares of the firm’s stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $346.52, for a total value of $136,182.36. Following the completion of the sale, the chief accounting officer now owns 9,473 shares in the company, valued at approximately $3,282,583.96. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, CAO Maurice Hebert sold 393 shares of the business’s stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $346.52, for a total transaction of $136,182.36. Following the transaction, the chief accounting officer now directly owns 9,473 shares in the company, valued at $3,282,583.96. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Steven J. Orlando sold 1,000 shares of the firm’s stock in a transaction dated Tuesday, July 30th. The shares were sold at an average price of $339.21, for a total transaction of $339,210.00. Following the completion of the sale, the director now owns 18,025 shares of the company’s stock, valued at approximately $6,114,260.25. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 1.10% of the stock is currently owned by corporate insiders.

Institutional Trading of Molina Healthcare

Institutional investors have recently modified their holdings of the business. Innealta Capital LLC purchased a new position in Molina Healthcare in the second quarter worth $36,000. Ashton Thomas Private Wealth LLC purchased a new position in shares of Molina Healthcare in the 2nd quarter valued at about $40,000. AM Squared Ltd purchased a new position in shares of Molina Healthcare in the 2nd quarter valued at about $59,000. UMB Bank n.a. lifted its stake in shares of Molina Healthcare by 96.2% in the third quarter. UMB Bank n.a. now owns 206 shares of the company’s stock valued at $71,000 after purchasing an additional 101 shares during the period. Finally, Fidelis Capital Partners LLC purchased a new stake in Molina Healthcare during the first quarter worth about $151,000. 98.50% of the stock is currently owned by hedge funds and other institutional investors.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.